Botox maker agrees to pay out $600 million for misbranding The Associated Press: Allergan Inc.

Harris said her office 8 weeks ago launched investigations in to the websites imitating coveredca. 1. The website operators were sent cease and desist letters informing them their sites violated state legislation and challenging their removal or transfer of their domains to the state exchange . Related StoriesPreventing falls in treatment homes: an interview with Professor Pip LoganInnovative IV pole utilizing polycarbonate resin blend from Bayer enhances patient and healthcare worker safetyInnovative single-make use of torque instruments utilize challenging polycarbonate from Bayer San Francisco Chronicle: State Shuts Down Bogus HEALTHCARE Websites Among the posers secured rights to the domain name, similar to the official, Harris said.Tim Bongartz, among the study co-authors. They also failed to note that a TNF medication made by Wyeth was not really contained in the study, even though these were working with Wyeth on another study. Matteson says he is embarrassed by the incident that was not intended to mislead; he and Dr. Bongartz have created an apology to JAMA. Dr. Catherine D. DeAngelis, JAMA’s editor-in-chief, says she was worried as she was first notified of the situation by among the drug businesses involved.